Cabaletta Bio (CABA) Amortizatization of Intangibles (2020 - 2025)
Cabaletta Bio's (CABA) quarterly Amortizatization of Intangibles came in at $890000.0 in Q4 2025, up 11.81% year-on-year from $796000.0 in Q4 2024, and up 150.0% quarter-over-quarter from $356000.0 in Q3 2025.
Cabaletta Bio (CABA) Amortizatization of Intangibles (2020 - 2025) Analysis & Trends
Cabaletta Bio's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $890000.0 for Q4 2025.
- On a quarterly basis, Amortizatization of Intangibles rose 11.81% year-over-year to $890000.0 in Q4 2025; TTM through Dec 2025 was $1.6 million, a 1.77% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 1.77% from the prior year.
- Amortizatization of Intangibles rose to $890000.0 in Q4 2025 per CABA's latest filing, from $356000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $890000.0 in Q4 2025 and bottomed at -$431000.0 in Q4 2023.
- The 5-year median for Amortizatization of Intangibles is $132000.0 (2022), against an average of $202888.9.
- Across the five-year window, Amortizatization of Intangibles tumbled 1036.96% in 2023 and jumped 4646.15% in 2024, its largest moves.
- Year by year, Amortizatization of Intangibles stood at -$12000.0 in 2021, then jumped by 483.33% to $46000.0 in 2022, then tumbled by 1036.96% to -$431000.0 in 2023, then jumped by 284.69% to $796000.0 in 2024, then advanced by 11.81% to $890000.0 in 2025.
- Per Business Quant, the three latest CABA Amortizatization of Intangibles figures stand at $890000.0 (Q4 2025), $356000.0 (Q3 2025), and $142000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Cabaletta Bio | 184.38 Mn | 184.38 Mn | - | 890,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 890,000.00 |
| Dec 31, 2025 | 890,000.00 |
| Sep 30, 2025 | 356,000.00 |
| Sep 30, 2025 | 356,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Mar 31, 2025 | 167,000.00 |
| Mar 31, 2025 | 167,000.00 |
| Dec 31, 2024 | 796,000.00 |
| Dec 31, 2024 | 796,000.00 |
| Sep 30, 2024 | 339,000.00 |
| Sep 30, 2024 | 339,000.00 |
| Jun 30, 2024 | -224,000.00 |
| Jun 30, 2024 | -224,000.00 |
| Mar 31, 2024 | 617,000.00 |
| Mar 31, 2024 | 617,000.00 |
| Dec 31, 2023 | -431,000.00 |
| Dec 31, 2023 | -431,000.00 |
| Sep 30, 2023 | 653,000.00 |
| Sep 30, 2023 | 653,000.00 |